October 1, 2009
By:Laura Bush
It seems clear that insuring the roughly 46 million Americans who are now uninsured will increase drug sales.
 |
September 1, 2009
By:Laura Bush
If risk assessments only identify "the usual suspects," the process will not add much value.
|
August 1, 2009
By:Laura Bush
Perhaps the best way to regulate drugs is to regulate them not conservatively or liberally, but effectively.
|
July 1, 2009
By:Laura Bush
The truth is, we should have been afraid of H1N1, because the threat of a flu pandemic is real.
|
June 1, 2009
By:Laura Bush
Importing foreign drugs is not the best way to increase access to medicine. The risks are too high, and it burdens the over-stretched FDA unfairly.
|
May 1, 2009
By:Laura Bush
Avoiding healthcare reform is not the best option for the pharmaceutical industry.
|
April 1, 2009
By:Laura Bush
The 45 comments submitted raised concerns about legacy products and ongoing process monitoring.
|
March 1, 2009
By:Laura Bush
At some point, will heavy investments in large, stainless-steel based facilities become a burden to US companies?
|
February 1, 2009
By:Laura Bush
How change plays out will depend not only on the new Whitehouse, but on pharma leaders' ability to adapt to changing times.
|
| 
